<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-OWCKIV1N</identifier><date>2009</date><creator>Locatelli, Igor</creator><creator>Stepanović, Aleksander</creator><creator>Tršinar, Mihaela</creator><relation>documents/doc/O/URN_NBN_SI_doc-OWCKIV1N_001.htm</relation><relation>documents/doc/O/URN_NBN_SI_doc-OWCKIV1N_001.pdf</relation><relation>documents/doc/O/URN_NBN_SI_doc-OWCKIV1N_001.txt</relation><format format_type="issue">2</format><format format_type="volume">60</format><format format_type="type">article</format><format format_type="extent">str. 98-104</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">2556017</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-OWCKIV1N</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">bolečina</subject><subject language_type_id="slv">nesteroidni antirevmatiki</subject><subject language_type_id="slv">neželeni učinki</subject><subject language_type_id="slv">paracetamol</subject><title>NSAID and paracetamol: challenges and pitfalls</title><title>NSAR in paracetamol: izzivi in pasti?</title></Record>